The new formulation of YOXA OROSOLUBILE is a powder that dissolves directly on the tongue. This allows for easier, faster, and more pleasant administration for the patient, compared to the previous granule formulation, which requires water and waiting for the suspension to dissolve.

Due to the frequent antibiotic treatments that patients must undergo from a very young age and also due to the intestinal problems caused by the disease itself, subjects with Cystic Fibrosis have a less rich intestinal microbiota.

In this context, Oxalobacter Formigenes, a microorganism responsible exclusively for oxalate metabolism, is often depleted, resulting in patients being 70 times more likely to develop calcium oxalate urolithiasis than healthy individuals. Oxalic acid also has a strong pro-inflammatory effect in the intestine.

Yoxa, granulated in sachets, is a symbiotic supplement based on live lactic ferments, formulated to compensate for the deficiency of the microorganism Oxalobacter Formigenes.

Yoxa contains 5 different bacterial strains, all selected for their unique ability to metabolize oxalates and for their intrinsic anti-inflammatory action.

The product must be used under medical supervision

Food supplement based on live lactic ferments, registered in the Ministry of Health's supplement register with code: 150699.

Pharmaceutical Code: 985638232

Each pack of YOXA OROSOLUBILE contains 30 stick packs